ATE199025T1 - Test zur diagnose eines erhöhten brustkrebs- risikos - Google Patents

Test zur diagnose eines erhöhten brustkrebs- risikos

Info

Publication number
ATE199025T1
ATE199025T1 AT97949440T AT97949440T ATE199025T1 AT E199025 T1 ATE199025 T1 AT E199025T1 AT 97949440 T AT97949440 T AT 97949440T AT 97949440 T AT97949440 T AT 97949440T AT E199025 T1 ATE199025 T1 AT E199025T1
Authority
AT
Austria
Prior art keywords
breast cancer
sequence
diagnosing
test
increased risk
Prior art date
Application number
AT97949440T
Other languages
English (en)
Inventor
Eldon R Jupe
Linda F Thompson
Regina Resta
Orco Robert T Dell
Original Assignee
Oklahoma Med Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Med Res Found filed Critical Oklahoma Med Res Found
Application granted granted Critical
Publication of ATE199025T1 publication Critical patent/ATE199025T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
AT97949440T 1996-11-07 1997-11-06 Test zur diagnose eines erhöhten brustkrebs- risikos ATE199025T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2997896P 1996-11-07 1996-11-07
PCT/US1997/020844 WO1998020167A1 (en) 1996-11-07 1997-11-06 Diagnostic assay for breast cancer susceptibility

Publications (1)

Publication Number Publication Date
ATE199025T1 true ATE199025T1 (de) 2001-02-15

Family

ID=21851898

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97949440T ATE199025T1 (de) 1996-11-07 1997-11-06 Test zur diagnose eines erhöhten brustkrebs- risikos

Country Status (8)

Country Link
US (1) US6355427B1 (de)
EP (1) EP0943017B1 (de)
JP (1) JP2001503276A (de)
AT (1) ATE199025T1 (de)
AU (1) AU723400B2 (de)
CA (1) CA2269664C (de)
DE (1) DE69704031T2 (de)
WO (1) WO1998020167A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69828647T2 (de) * 1997-11-06 2005-12-01 Oklahoma Medical Research Foundation, Oklahoma Diagnostisches assay zur krebsanfälligkeit
EP1100892B1 (de) * 1998-07-24 2008-04-09 Oklahoma Medical Research Foundation Verwendung von prohibitin-rns in krebsbehandlung
US7273855B2 (en) 1999-07-24 2007-09-25 Oklahoma Medical Research Foundation Use of prohibitin RNA in treatment of cancer
US7238475B2 (en) * 2001-08-27 2007-07-03 The Regents Of The University Of California Apolipoprotein gene involved in lipid metabolism
US20040002071A1 (en) * 2001-09-19 2004-01-01 Intergenetics, Inc. Genetic analysis for stratification of cancer risk
RU2222813C1 (ru) * 2003-04-22 2004-01-27 Центральный научно-исследовательский рентгено-радиологический институт Способ прогнозирования продолжительности жизни больных при распространенных злокачественных новообразованиях
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
BRPI0513057A (pt) 2004-07-08 2008-04-22 Exxonmobil Chem Patents Inc produção de polìmero em condições supercrìticas
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
EP2468901B1 (de) * 2005-11-29 2017-04-05 Cambridge Enterprise Limited Marker für Brustkrebs
US20090226912A1 (en) * 2007-12-21 2009-09-10 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
CN102712949B (zh) 2009-06-01 2015-12-16 遗传技术有限公司 用于乳腺癌风险评估的方法
US9732389B2 (en) 2010-09-03 2017-08-15 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
US9534256B2 (en) 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
JP6820838B2 (ja) 2014-09-30 2021-01-27 ジェネティック テクノロジーズ リミテッド 乳癌発症リスクを評価する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271294A (ja) 1992-01-24 1993-10-19 Japan Found Cancer Res ヒトプロヒビチンおよびそれをコードするｄｎａ
US5922852A (en) * 1995-06-07 1999-07-13 Oklahoma Medical Research Foundation 3' untranslated region of the human prohibitin gene

Also Published As

Publication number Publication date
US6355427B1 (en) 2002-03-12
JP2001503276A (ja) 2001-03-13
DE69704031D1 (de) 2001-03-08
AU7002398A (en) 1998-05-29
DE69704031T2 (de) 2001-06-13
AU723400B2 (en) 2000-08-24
CA2269664C (en) 2007-08-07
WO1998020167A1 (en) 1998-05-14
EP0943017B1 (de) 2001-01-31
EP0943017A1 (de) 1999-09-22
CA2269664A1 (en) 1998-05-14

Similar Documents

Publication Publication Date Title
DE69704031D1 (de) Test zur diagnose eines erhöhten brustkrebs-risikos
Marcon et al. Assessment of individual sensitivity to ionizing radiation and DNA repair efficiency in a healthy population
WO2000004187A3 (en) Methods and kits for diagnosing and determination of the predisposition of diseases
FR2755149B1 (fr) Procede de diagnostic de maladies genetiques par peignage moleculaire et coffret de diagnostic
NZ331376A (en) Methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
GB2383043A (en) Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain
ATE360092T1 (de) Nukleinsäureprimer und -sonden zur detektion onkogener humaner papillomaviren
Mertelsmann et al. Improved biochemical assay for terminal deoxynucleotidyl transferase in human blood cells: Results in 89 adult patients with lymphoid leukemias and malignant lymphomas in leukemic phase
IL142971A0 (en) S100 proteins and autoantibodies as serum markers for cancer
ATE164630T1 (de) Verfahren und reagenzien für die karakterisierung von hla-drbeta-dns
WO1997030179B1 (en) Determining exposure to ionizing radiation agent with persistent biological markers
US5945289A (en) Method for detecting prostate cancer by apolipoprotein E (Apo-E) genotyping
Higginson The role of the pathologist in environmental medicine and public health
DK0515660T3 (da) HLA-DQbeta-DNA-typebestemmelse
Okamoto et al. Polymorphism of 5-methylcytosine-rich DNA in human acrocentric chromosomes
DE69710469D1 (de) Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus
Harada et al. New phenotypes of serum α 1-antitrypsin in Japanese detected by gel slab isoelectric focusing
FI990380A0 (fi) Diagnostinen ja seulontamenetelmä
ATE440138T1 (de) Mutationen des parkin-gens, zusammensetzungen, verfahren und verwendungen
CA2308766A1 (en) Diagnostic assay for cancer susceptibility
Yasuda et al. Population studies of human deoxyribonuclease I polymorphism
Ling et al. Sensitivity of PCR in detecting monoclonal B cell proliferations.
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
EP0920538A4 (de) Verfahren zur diganose und feststellung der prädisposition von bipolaren gemütserkrankungen
DE60237406D1 (de) Aus einem Neuroblastom isolierte Nukleinsäuren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee